Inventor · disambiguated record
John Cumming
Also filed as: CUMMING JOHN · CUMMING JOHN G · CUMMING JOHN GRAHAM
18 granted patents·18 pending applications·369 citations·filing 1997–2024
94Inventor score
Files withASTRAZENECA AB11CUMMING JOHN5HOFFMANN LA ROCHE4SECRET LOCATION INC4HEPTARES THERAPEUTICS LTD2
Top patents by PatentIndex Score
36 records- 0194US9891910B1Systems and methods for pre-processing and runtime distribution of interactive contentSECRET LOCATION INC·Filed 2017·Granted Feb 13, 2018·19 cites·16 claims
- 0293US6313127B1Heterocyclic compounds useful as pharmaceutical agentsZENECA LTD·Filed 1997·Granted Nov 6, 2001·139 cites·17 claims
- 0388US6593333B1Substituted anilino-quinazoline (or quinoline) compounds and use thereofASTRAZENECA AB·Filed 1999·Granted Jul 15, 2003·74 cites·12 claims
- 0486US6784174B1Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated diseaseASTRAZENECA AB·Filed 2000·Granted Aug 31, 2004·29 cites·13 claims
- 0585US6716847B2Substituted anilino-quinoline compounds and use thereofASTRAZENECA AB·Filed 2003·Granted Apr 6, 2004·22 cites·9 claims
- 0684US7741360B2Bi-aryl or aryl-heteroaryl substituted indolesASTRAZENECA AB·Filed 2007·Granted Jun 22, 2010·6 cites·15 claims
- 0778US6846827B1Pyrimidine derivativesASTRAZENECA AB·Filed 2000·Granted Jan 25, 2005·13 cites·12 claims
- 0877US10550089B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·1 cites·7 claims
- 0976US7294636B2Chemical compoundsASTRAZENECA AB·Filed 2004·Granted Nov 13, 2007·9 cites·17 claims
- 1073US6960602B2Piperidine derivatives as modulators of chemokine receptorsASTRAZENECA AB·Filed 2002·Granted Nov 1, 2005·7 cites·10 claims
- 1172US6989393B2Ccr5 modulators benzimidazoles or benzotriazolesASTRAZENECA AB·Filed 2001·Granted Jan 24, 2006·6 cites·6 claims
- 1270US10133567B1Systems and methods for pre-processing and runtime distribution of interactive contentSECRET LOCATION INC·Filed 2018·Granted Nov 20, 2018·1 cites·20 claims
- 1367US6144387AGuard region and hither plane vertex modification for graphics renderingFiled 1998·Granted Nov 7, 2000·43 cites·14 claims
- 1465US10995072B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 4, 2021·0 cites·13 claims
- 1565US2010152197A1(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivativesASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1664US2024252506A1Compounds for treatment of bacterial infectionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1764US2024254140A1Compounds and their use in the treatment of bacterial infectionHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1856US7943776B2Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsASTRAZENECA AB·Filed 2004·Granted May 17, 2011·0 cites·15 claims
- 1956US2019289277A1Systems and methods for procedural rendering of cinematic virtual reality contentSECRET LOCATION INC·Filed 2019·Application pending·0 cites
- 2056US2013289043A1(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivativesCUMMING JOHN·Filed 2013·Application pending·0 cites
- 2155US2023167127A1Compounds and their use in the treatment of bacterial infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2254US8742124B2Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsASTRAZENECA AB·Filed 2012·Granted Jun 3, 2014·0 cites·9 claims
- 2354US2012289513A1(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivativesCUMMING JOHN·Filed 2012·Application pending·0 cites
- 2452US10313653B1Systems and methods for procedural rendering of cinematic virtual reality contentSECRET LOCATION INC·Filed 2017·Granted Jun 4, 2019·0 cites·19 claims
- 2548US2012004243A1Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitorsBROWN DEARG SUTHERLAND·Filed 2011·Application pending·0 cites
- 2647US2006205769A1Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activityBROWN DEARG·Filed 2004·Application pending·0 cites
- 2745US2006189650A1Novel piperidine derivatives as modulators of chemokine receptor ccr5CUMMING JOHN·Filed 2003·Application pending·0 cites
- 2844US10597380B2Pyridazinone-based broad spectrum anti-influenza inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·0 cites·42 claims
- 2943US2004266823A1Novel piperidine derivatives as modulators of chemokine receptorsCUMMING JOHN·Filed 2002·Application pending·0 cites
- 3043US2010311797A1Novel CompoundsBONNERT ROGER VICTOR·Filed 2010·Application pending·0 cites
- 3143US2005171353A1Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)Filed 2003·Application pending·0 cites
- 3243US2005014788A1Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)Filed 2002·Application pending·0 cites
- 3340US2004110952A1N-4-piperidinyl compounds as ccr5 modulatorsFiled 2002·Application pending·0 cites
- 3440US2004122049A1Novel piperidine derivatives as modulators of chemokine receptorFiled 2002·Application pending·0 cites
- 3539US2006167048A1N-4-piperidinyl compounds as ccr5 modulatorsCUMMING JOHN·Filed 2003·Application pending·0 cites
- 3635US2004006081A1Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activityFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Cumming files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →